期刊文献+

急性冠脉综合征患者Th/Tregs水平的变化及其临床意义 被引量:9

Evaluation of plasma Th/Tregs levels in patients with acute coronary syndrome and their clinical significance
下载PDF
导出
摘要 目的研究白介素17(IL-17)、白介素35(IL-35)在急性冠脉综合征(ACS)患者外周血中的表达,探讨该指标与肌钙蛋白I(c Tn I)、B型钠尿肽(BNP)及左室射血分数(LVEF)等是否存在相关性。方法选取2016年7月至2017年9月在广州中医药大学第一附属医院住院的ACS患者143例,其中ST段抬高型急性心肌梗死(STEMI)37例,非ST段抬高型急性心肌梗死(NSTEMI)45例,不稳定心绞痛61例;同期体检健康者30例为对照组。以ELISA法检测血清IL-17、IL-35水平,超声心动图Simpson法测定LVEF值。指标间相关性采用Pearson相关分析。结果 STEMI组患者的IL-35、IL-17水平[40.71±14.96)pg/m L、(45.72±13.75)pg/m L]与UAP组[(79.84±21.41)pg/m L、(15.64±9.83)pg/m L]比较差异均有统计学意义(P<0.05),而STEMI与NSTEMI组患者的IL-35水平[(45.96±17.52)pg/m L]和IL-17水平[(39.13±10.94)pg/m L]比较差异均无统计学意义(P>0.05);ACS患者IL-17水平与c Tn I、BNP及D-Dimer呈负相关(r=-0.652,-0.571,-0.484,P<0.05),与LVEF呈正相关(r=0.436,P<0.05);IL-35水平与c Tn I、BNP及D-Dimer呈正相关(r=0.573,0.416,0.597,P<0.05),与LVEF呈负相关(r=-0.391,P<0.05)。结论 ACS患者外周血IL-17、IL-35水平在一定程度上能反映ACS的病情严重程度,可作为冠心病急性心血管事件的独立预测指标。 Objective To investigate the levels of IL-17 and IL-35 in patients with acute coronary syndrome(ACS), and to explore the correlation between them and cardiac troponin I(c Tn I), brain natriuretic peptide(BNP), left ventricular ejection fraction(LVEF). Methods A total of 143 cases of patients with ACS, including 45 cases of ST elevation acute myocardial infarction(STEMI), 37 cases of non-ST segment elevation acute myocardial infarction(NSTEMI), and61 cases of unstable angina patients(UAP), who admitted to the First Affiliated Hospital of Guangzhou University of Chinese Medicine from July 2016 to September 2017, were selected as the research subjects. At the same time, a total of 30 cases of physical examination in our hospital were selected as the control group. Serum IL-17, IL-35 were detected by ELISA, and the echocardiography LVEF values were determined by Simpson method. The correlation between the indexes was analyzed by Pearson correlation. Results The levels of IL-35 and IL-17 were respectively(40.71±14.96) pg/m L and(45.72±13.75) pg/m L in the STEMI group versus corresponding(79.84±21.41) pg/m L and(15.64±9.83) pg/m L in the UAP group(P〈0.05); but there was there was no significant difference between the STEMI and NSTEMI group,(45.96±17.52) pg/m L and(39.13±10.94) pg/m L, in the levels of IL-35 and IL-17(P〉0.05). The level of IL-35 in the patients with ACS were negatively correlated with c Tn I, BNP, D-Dimer(r=-0.652,-0.571,-0.484, respectively), and positively correlated with LVEF(r=0.436, P〈0.05); while the IL-17 level were positively correlated with c Tn I, BNP, D-Dimer(r=0.573, 0.416, 0.597, P〈0.05), and negatively correlated with LVEF(r=-0.391, P〈0.05). Conclusion The levels of IL-17 and IL-35 in the peripheral blood of ACS patients can reflect the severity of ACS in a certain extent, and can be used as an independent predictor of acute cardiovascular events in coronary heart disease.
作者 余锋 信梦雪 刘静 洪永敦 刘南 赵静 YU Feng;XIN Meng-xue;LIU Jing;HONG Yong-dun;LIU Nan(Department of Emergeney1, Department of Naonatology;the First Affiliated Hospital of Gaangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, CHINA)
出处 《海南医学》 CAS 2018年第11期1486-1489,共4页 Hainan Medical Journal
基金 广东省中医药局建设中医药强省科研项目(编号:20161126)
关键词 冠心病 急性冠脉综合征 调节T淋巴细胞 白介素17 白介素-35 炎症免疫 Coronary heart disease Acute coronary syndrome (ACS) Th/Tregs IL-17 IL-35 Immune inflammatory
  • 相关文献

参考文献3

二级参考文献22

  • 1李大主,胡英锋,杨克平,曾秋棠,李裕舒,王祥,冯义柏,曹林生.急性冠状动脉综合征患者调节性T细胞变化与炎症反应的关系[J].中国循环杂志,2006,21(5):337-339. 被引量:15
  • 2Libby P, Okamoto Y, Rocha V Z, et al. Inflammation in atherosclerosis: transition from theory to practice [J]. Circ J, 2010,74(2) : 213-220.
  • 3Taleb S, Tedgui A, Mallat Z. Adaptive T cell immune responses and atherogenesis [J]. Curr Opin Pharmacol, 2010, 10(2) : 197-202.
  • 4Kilic T, Ural D, Ural E, et al. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome [J]. Heart, 2006,92(8) : 1041-1046.
  • 5Niedbala W, Wei X Q, Cai B, : et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th 17 ceils [ J ]. Eur J Immunol, 2007,37 ( 11 ) : 3021-3029.
  • 6Collison L W, Workman C J, Kuo T T, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function [J]. Nature, 2007,450(7169) : 566-569.
  • 7Mor A, Luboshits G, Planer D, et al. Altered Status of CD4 (+)CD25(+) regulatory T cells in patients with acute coronary syndromes [J]. Eur Heart J, 2006,27(21 ) : 2530-2537.
  • 8Chaturvedi V, Collison L W, Guy C S, et al. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance [J]. J Immunol, 2011,186(12): 6661-6666.
  • 9Li X, Mai J, Virtue A, et al. IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti- inflammatory cytokines [J]. PLoS One, 2012,7(3) :e33628.
  • 10Collison L W, Pillai M R, Chaturvedi V, et al. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner [J]. J Immunol, 2009,182(10) : 6121-6128.

共引文献25

同被引文献109

引证文献9

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部